04:23 PM EDT, 05/24/2024 (MT Newswires) -- Peter Salzmann, Director, Chief Executive Officer, on May 22, 2024, sold 16,163 shares in Immunovant ( IMVT ) for $479,233. Following the Form 4 filing with the SEC, Salzmann has control over a total of 1,036,716 shares of the company, with 1,036,716 shares held directly.

SEC Filing:

https://www.sec.gov/Archives/edgar/data/1764013/000176401324000098/xslF345X03/wk-form4_1716581737.xml